[-] Show simple item record

dc.contributor.advisorLever, Susan Z., 1952-en
dc.contributor.authorXu, Rong, 1977-en_US
dc.date.issued2007eng
dc.date.submitted2007 Summeren
dc.descriptionThe entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file.en_US
dc.descriptionTitle from title screen of research.pdf file (viewed on December 18, 2007)en_US
dc.descriptionVita.en_US
dc.descriptionIncludes bibliographical references.en_US
dc.descriptionThesis (Ph. D.) University of Missouri-Columbia 2007.en_US
dc.descriptionDissertations, Academic -- University of Missouri--Columbia -- Chemistry.en_US
dc.description.abstractThe sigma receptor is a unique receptor family that has two subtypes: sigma1 and sigma2. Sigma1 receptors are involved in several physiological functions such as psychosis and depression. Sigma2 receptors are expressed in a variety of human tumors. Thus the selective sigma1 ligands have potential usage in central nervous system diseases, while sigma2 selective ligands can play an important role as biomarkers and therapeutic agents of tumor proliferation. Two well characterized compounds, SA4503 and conformationally flexible benzamide were chosen as our leads. Structural modifications were conducted in order to study the effect of structural elements on sigma binding properties; the possibility of new ligands as potential SPECT imaging agents was also explored. The result showed most of the SA4503 analogs had moderate affinity and no selectivity between sigma1 and sigma2 receptor subtype. All of these analogs had increased binding affinity for sigma2 subtype than their lead compound SA4503. The modifications made by replacing the left phenylpropyl group of SA4503 with an N-iodoallyl group yielded a sigma1 selective ligand (1h-7, E-IA-DM-PE-PIPZ) that had appropriate lipophilicity for penetrating the blood brain barrier in the CNS. The in vivo studies using radioiodinated 1h-7 showed that it had high specific binding to the sigma1 receptor in the mouse brain and thus it had great potential as SPECT agent for brain imaging. The modifications on the benzamide series of compounds by rigid dioxy rings showed similar trend in binding affinities as observed in the similar modification made on theSA4503 phenolic side chain, the most rigid methylenedioxy analog had the highest affinity and the least rigid propylenedioxy had the lowest affinity for sigma1 subtype. Sigma2 affinity was not affected significantly by the size of the dioxy ring. The modification of the strained tetrahydroisoquinoline ring with a freely rotating amine chain maintained the sigma1 affinity unchanged, while decreasing the sigma2 binding affinity dramatically. Thus a rigid tetrahydroisoquinoline is an important structural element for selective sigma2 binding in the benzamides series compounds.en_US
dc.identifier.merlin.b61533245en_US
dc.identifier.oclc184845644en_US
dc.identifier.otherXuR-072407-D7771en_US
dc.identifier.urihttp://hdl.handle.net/10355/4742
dc.publisherUniversity of Missouri--Columbiaen_US
dc.relation.ispartof2007 Freely available dissertations (MU)en_US
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. Graduate School. Theses and Dissertations. Dissertations. 2007 Dissertations
dc.subject.lcshSigma receptorsen_US
dc.subject.lcshCentral nervous system -- Diseasesen_US
dc.subject.lcshBiochemical markersen_US
dc.subject.lcshAnalytical biochemistryen_US
dc.subject.lcshLigand binding (Biochemistry)en_US
dc.subject.lcshProtein bindingen_US
dc.titleThe effects of structural modifications on sigma receptor bindingen_US
dc.typeThesisen_US
thesis.degree.disciplineChemistry (MU)eng
thesis.degree.grantorUniversity of Missouri--Columbiaeng
thesis.degree.levelDoctoraleng
thesis.degree.namePh. D.eng


Files in this item

[PDF]
[PDF]
[PDF]

This item appears in the following Collection(s)

[-] Show simple item record